UMB Bank’s Relay Therapeutics RLAY Stock Holding History

UMB Bank’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.31K	Hold	735	–	–	﹤0.01%	1953
2025 Q4	$6.22K	Hold	735	–	–	﹤0.01%	1964
2025 Q3	$3.84K	Buy	+735	New	+$2.8K	﹤0.01%	1943

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UMB Bank's RLAY Position: Q1 2026 in Review

UMB Bank held its Relay Therapeutics (RLAY) position steady in Q1 2026 at 735 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

UMB Bank first reported a position in RLAY in Q3 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

UMB Bank held 735 shares of Relay Therapeutics worth $7.31K as of Q1 2026.
UMB Bank left its Relay Therapeutics share count unchanged in Q1 2026.
Relay Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1953 holding.
UMB Bank first reported a position in Relay Therapeutics in Q3 2025 and has held it in 3 quarters since.
242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.